News Hacking ring seeks to extort Novo Nordisk after cyberattack FulcrumSec has reportedly offered data from a Novo Nordisk breach for sale after a $25m ransom was rejected, but has a second breach also occurred?
News Patient information exposed in breach, says Novo Nordisk Novo Nordisk has become the latest pharma group to be targeted by a cyberattack, confirming a breach exposed some patient data.
News UK approves Novo Nordisk's Wegovy pill Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.
News ADA: Lilly's weight-loss reveal, and wannabes display wares Lilly reveals more details of its retatrutide obesity and diabetes studies, plus trial updates from Zealand/Roche, Pfizer, Novo Nordisk, and Sciwind.
News France 'first EU country to cover obesity drugs' France's Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies.
News Oral Wegovy backed by CHMP at May meeting The CHMP recommended eight new medicines and 13 line extensions at its May meeting, including Novo Nordisk's oral weight loss therapy.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.